Skip to main content
Premium Trial:

Request an Annual Quote

Wash. U. Gains Access to GeneChips, Sequencers

Premium

ST. LOUIS--Washington University recently closed deals with Affymetrix for GeneChip access and Amersham Pharmacia Biotech to purchase MegaBace sequencing machines. Affymetrix and the university signed an AcademicAccess agreement to grant the school's researchers use of the company's standard and custom GeneChip arrays, instrumentation, and software to monitor gene expression for research purposes. The arrangement, which includes standard terms, conditions, and volume discount pricing provisions, will allow all of the university's researchers broad access to GeneChip technology.

Under the Amersham contract, the university's school of medicine purchased nine MegaBace 1000 DNA sequencers for its activities contributing to the Human Genome Project. The university's medical school receives funding for the project from the US National Human Genome Research Institute at the US National Institutes of Health.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.